Contact
Please use this form to send email to PR contact of this press release:
Valneva Announces Positive Initial Results for Phase 2 Study of Lyme Disease Vaccine Candidate
TO:
Please use this form to send email to PR contact of this press release:
Valneva Announces Positive Initial Results for Phase 2 Study of Lyme Disease Vaccine Candidate
TO: